Whales with a lot of money to spend have taken a noticeably bearish stance on Humana.

Looking at options history for Humana (NYSE:HUM) we detected 12 trades.

If we consider the specifics of each trade, it is accurate to state that 16% of the investors opened trades with bullish expectations and 83% with bearish.

From the overall spotted trades, 8 are puts, for a total amount of $366,849 and 4, calls, for a total amount of $263,700.

Projected Price Targets

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $320.0 and $470.0 for Humana, spanning the last three months.

Insights into Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Humana's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Humana's whale activity within a strike price range from $320.0 to $470.0 in the last 30 days.

Humana Option Volume And Open Interest Over Last 30 Days

Largest Options Trades Observed:

About Humana

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Following our analysis of the options activities associated with Humana, we pivot to a closer look at the company's own performance.

Current Position of Humana

• Currently trading with a volume of 507,508, the HUM's price is down by -0.22%, now at $457.28.
• RSI readings suggest the stock is currently may be approaching oversold.
• Anticipated earnings release is in 28 days.

Expert Opinions on Humana

1 market experts have recently issued ratings for this stock, with a consensus target price of $550.0.

• Showing optimism, an analyst from Argus Research upgrades its rating to Buy with a revised price target of $550.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humana with Benzinga Pro for real-time alerts.